NASDAQ · Medical Instruments & Supplies · USD
Embecta Corp. (EMBC) Stock Analysis
Embecta Corp. (EMBC) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
EMBC Key Statistics
As of Oct 21, 2026Trading
- Open
- $6.37
- Previous Close
- $6.42
- Day's Range
- 6.35–6.74
- 52-Week Range
- 2.77–14.91
- Volume
- 706.69K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.83
Valuation
- Market Cap
- $378.49M
- P/E Ratio
- 4.54
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 3.79
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.37
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 1.47
Financials (FY)
- Revenue (FY)
- $1.08B−3.80%
- Net Income (FY)
- $95.40M+21.84%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 8.59%
- Shares Outstanding
- 56.66M
- 1-Year Return
- −51.85%
Dividend and dates
- Dividend
- $0.04+0.62%
- Ex-Dividend Date
- August 27, 2026
- Earnings Date
- November 25, 2026
- Avg Volume
- 1.29M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, EMBC closed at $6.68, −51.85% over 1 year.
Embecta Corp. (EMBC) has a market capitalization of $378.49M.
In fiscal 2025, EMBC reported revenue of $1.08B.
EMBC Stock Return by Calendar Year
Embecta Corp. (EMBC) return since Mar 2022: what $10,000 became
- 1 year
- $10,000 $4,815
- −51.85%
- 3 years
- $10,000 $4,829
- −51.71%
- Since Mar 2022
- $10,000 $1,640
- −83.60%
If you had invested $10,000 in Embecta Corp. (EMBC) at the close on March 22, 2022, the earliest close on record here, it would have been worth $1,640 at the close on October 21, 2026: −83.60% in total, −32.60% a year, with dividends reinvested, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −42.78% |
| 2025 | −39.64% |
| 2024 | +13.56% |
| 2023 | −23.12% |
| 2022 (partial year) | −45.62% |
As of October 21, 2026.
EMBC Revenue and Earnings by Fiscal Year
FY ends September| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $1.08B | $95.40M | 8.8% |
| 2024 | $1.12B | $78.30M | 7.0% |
| 2023 | $1.12B | $70.40M | 6.3% |
| 2022 | $1.13B | $223.60M | 19.8% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $1.08B | $676.80M | $296.40M | $95.40M | 8.8% |
| 2024 | $1.12B | $735.20M | $285.00M | $78.30M | 7.0% |
| 2023 | $1.12B | $749.90M | $224.00M | $70.40M | 6.3% |
| 2022 | $1.13B | $774.90M | $368.50M | $223.60M | 19.8% |
Annual figures as reported, in the company's reporting currency. As of September 30, 2025.
EMBC Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $0.17 | 3 | — |
| 2025 | $0.60 | 4 | +0.0% |
| 2024 | $0.60 | 4 | +0.0% |
| 2023 | $0.60 | 4 | +100.0% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $0.17 | 3 | — |
| 2025 | $0.60 | 4 | +0.0% |
| 2024 | $0.60 | 4 | +0.0% |
| 2023 | $0.60 | 4 | +100.0% |
| 2022 | $0.30 | 2 | — |
Most recent payment: $0.06 per share, ex-dividend August 27, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
EMBC Valuation vs Medical Instruments & Supplies Median
Median of 50 stocks| Metric | EMBC | Medical Instruments & Supplies median | vs median |
|---|---|---|---|
| P/E | 4.54 | 31.19 | 0.1x the median |
| P/S ratio | 0.37 | 2.60 | 0.1x the median |
| Profit margin | 8.59% | 1.62% | 7.0 pts above |
Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
What Embecta Bears Saw Before A 55% Drop
YahooThe Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products
SeekingAlphaEmbecta Corp. (EMBC) Q3 2026 Earnings Call Transcript
SeekingAlphaEmbecta Corp. 2026 Q3 - Results - Earnings Call Presentation
SeekingAlphaEmbecta (NASDAQ:EMBC) Jumps 9% on Strong Fiscal Q3 Earnings Beat
ChartMillEmbecta Raises FY2026 Adj EPS Guidance from $1.55-$1.75 to $1.80-$1.90 vs $1.59 Est; Affirms FY2026 Sales Guidance of $1.015B-$1.035B vs $1.021B Est
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Medical Instruments & Supplies Stocks
Intuitive Surgical, Inc.
$151.25B
BDXBecton, Dickinson and Company
$52.79B
MDLNMedline Inc.
$47.51B
RMDResMed Inc.
$34.63B
ALCAlcon Inc.
$32.60B
WSTWest Pharmaceutical Services, Inc.
$27.69B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B